References
- 1. Beth-Tasdogan NH, Mayer B. Hussein, H, Zolk O. Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst. Rev. 2017;10.10.1002/14651858.CD012432.pub2648585928983908
- 2. El-Rabbany M, Sgro A, Lam DK, Shah PS, Azarpazhooh A. Effectiveness of treatments for medication-related osteonecrosis of the jaw: A systematic review and meta-analysis. J. Am. Dent. Assoc. 2017;148:584–94.
- 3. Hasegawa T, Kawakita A, Ueda, N, Funahara R, Tachibana A, Kobayashi M, Kondou E, Takeda D, Kojima Y, Sato S et al. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: Can primary wound closure and a drug holiday really prevent MRONJ? Osteoporos. Int. 2017;28:2465–73.10.1007/s00198-017-4063-728451732
- 4. Giudice A, Barone S, Giudice C, Bennardo F, Fortunato L. Can platelet-rich fibrin improve healing after surgical treatment of medication-related osteonecrosis of the jaw? A pilot study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2018;126:390–403.10.1016/j.oooo.2018.06.00730108028
- 5. Thakkar DJ, Deshpande NC, Dave DH, Narayankar SD. A comparative evaluation of extraction socket preservation with demineralized freeze-dried bone allograft alone and along with platelet-rich fibrin: A clinical and radiographic study. Contemp. Clin. Dent. 2016;7:371–6.
- 6. Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi A. Tooth Extraction in Patients Taking Intravenous Bisphosphonates: A Preventive Protocol and Case Series. J. Oral Maxillofac. Surg. 2010;68:107–10.
- 7. Tsolov R, Firkova E, Yordanov G. Advanced stage 3 medication-related osteonecrosis of the mandible in a cancer patient on denosumab therapy (A case report), Biocell. 2019;43(5-1):240-4.
- 8. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone of the jaws: risk factors, recognition, prevention and treatment. J Oral Maxillofac Surg. 2005;63(11):1567-75.10.1016/j.joms.2005.07.01016243172
- 9. Fliefel R, Tröltzsch M, Kühnisch J, Ehrenfeld M, Otto S. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Max Surg. 2015;44(5):568-85.10.1016/j.ijom.2015.01.02625726090
- 10. Chisini LA, Arangurem Karam S, Noronha TG, Morello Sartori LR, Schmidt San Martin A, Demarco FF, Muniz Conde MC. Platelet-poor plasma as a supplement for fibroblasts cultured in platelet-rich fibrin. Acta stomatologica Croatica. 2017;51(2),133-40.
- 11. Ji X, Pushalkar Sр, Li Y, Glickman R, Fleisher K, Saxena D. Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral diseases. 2012;18(1),85-95.
- 12. Ristow O, Pautke C. Auto-fluorescence of the bone and its use for delineation of bone necrosis. Int J Oral Max Surg. 2014; 43(11):1391-3.10.1016/j.ijom.2014.07.01725128260
- 13. Tzolov R, Firkova E, Yordanov G. Comparative analysis of the healing process after conservative and surgical treatment of Medicamentally Induced Osteonecrosis of the Jaws, Bulgarian medical journal. 2019;2(21).
- 14. Tsolov R, Firkova E, Chenchev I, Yordanov G, Paecheva S. Bisphosphonate – related osteonecrosis of the jaw a 3-years retrospective study of frequency and risk factors, J of IMAB – Annual Proceeding (Scientific Papers). 2019;25(3):2617-21.